Table 4: Investigation profiles of patients.

Investigation Frequency (%)

Ascitic gram stain (n=24)Positive2(8.3)
Negative22(91.7)
Ascitic AFB stain (n=24)Yes0(0)
No24(100)
Hepatitis B surface antigen (n=52)Not determined10(19.2)
Positive9(17.3)
Negative33(63.5)
Anti-Hepatitis C antibody (n=52)Not determined11(21.2)
Yes4(7.7)
No37(71.2)
Antinuclear antibody (n=52)Not determined50(96.2)
Negative2(3.8)
HIV test (n=52)Not determined39(75)
Positive2(3.8)
Negative11(21.2)